Vitalibis, Inc. (VCBD)
OTCMKTS · Delayed Price · Currency is USD
0.0014
-0.0001 (-6.67%)
At close: Aug 28, 2025
Vitalibis Revenue
Vitalibis had revenue of $73.66K in the quarter ending September 30, 2020, with 39.00% growth. This brings the company's revenue in the last twelve months to $243.57K, down -1.86% year-over-year. In the year 2019, Vitalibis had annual revenue of $303.20K with 490.67% growth.
Revenue (ttm)
243.57K
Revenue Growth
-1.86%
P/S Ratio
2.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
552.39K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2019 | 303.20K | 251.87K | 490.67% |
| Dec 31, 2018 | 51.33K | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 105.45M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |